Recital 3, Directive (EU) 2003/12

In forcesince 3 Feb 2003cited 1×

In order to ensure the highest possible level of safety for breast implants, notified bodies should, under the full quality assurance system, carry out an examination of the design dossier of the product in accordance with point 4 of Annex II to Directive 93/42/EEC. Consequently, it is necessary to proceed to the reclassification of breast implants as Class III medical devices.

  • Opinion of Advocate General Sharpston delivered on 15 September 2016. Elisabeth Schmitt v TÜV Rheinland LGA Products GmbH.Decision

    By virtue of Article 1 of Directive 2003/12, [Commission Directive 2003/12/EC of 3 February 2003 on the reclassification of breast implants in the framework of Directive 93/42 (OJ 2003 L 28, p. 43).] ‘in order to ensure the highest …

    15 Sep 2016 · 62015CC0219